Publications by authors named "Kuo Guo"

Advanced prostate cancer (aPCa) often results in bone metastases (BM). However, the mechanism underlying its progression and metastasis to bones remains unclear. Therefore, we examined whether exosomal miR-140-3p affects prostate cancer (PCa) progression.

View Article and Find Full Text PDF

The objective of this study was to explore the effects of a 7-week short sprint interval training (SSIT) with differing in programming volume-loads including progressive (P-SSIT) and nonprogressive (NP-SSIT) approaches on the immunoendocrine, physical fitness attributes and physiological parameters in male wrestlers during the pre-season. Thirty young freestyle wrestlers at the collegiate national-level were included in the study and were divided into three groups: P-SSIT (n = 10), NP-SSIT (n = 10), and an active control group (n = 10). The wrestlers engaged in their specific wrestling training three days weekly, while the P-SSIT and NP-SSIT groups underwent a 7-week SSIT, with scheduling in either progressed or nonprogressed volume-based overloads, three times per week.

View Article and Find Full Text PDF
Article Synopsis
  • - Chronic nonbacterial prostatitis (CNP) causes painful and frequent urination, significantly impacting the quality of life, and the role of dihydroartemisinin (DHA) in treating CNP is not fully understood.
  • - In a study using a mouse model for CNP, DHA was found to reduce prostate tissue damage, alleviate pain, and decrease inflammation markers, while also affecting microRNA expression.
  • - The findings suggest that DHA helps improve CNP by regulating specific miRNAs and signaling pathways related to inflammation and tissue damage.
View Article and Find Full Text PDF

Objective: To investigate the efficacy of Bushen Huoxue Decoction (BSHXD) combined with moxibustion on inflammation and urinary symptoms in prostate cancer (PC) patients.

Methods: A total of 87 patients with PC admitted to the Hebei Provincial Hospital of Traditional Chinese Medicine from 08/2019 to 12/2021 were collected for this retrospective study. There were 42 patients treated with conventional treatment regimens who were regarded as the control group (CG).

View Article and Find Full Text PDF
Article Synopsis
  • In this study, researchers investigated the immune cell subtype diversity in prostate cancer (PC) using various analysis methods, including ssGSEA and NMF, to categorize patients based on immune cell infiltration and progression-free survival (PFS).
  • They identified two main clusters (clusterA with better PFS and clusterB with poorer PFS), highlighting that immune cell abundances and checkpoint gene expressions, such as CTLA-4 and PD-L1, varied significantly between these clusters.
  • Additionally, an immune score (IS) was developed to predict patient outcomes, revealing that low IS is linked to a better prognosis, particularly in patients receiving hormone therapy, suggesting IS could enhance prognosis prediction when combined with other
View Article and Find Full Text PDF

Software-Defined Network is an emerging networking paradigm that enables intelligent and flexible network management. Specifically, the design of the control plane is crucial. Therefore, in order to avoid a single point of failure, multiple controllers are deployed constantly in a distributed manner on the control plane.

View Article and Find Full Text PDF

Objective: Chronic nonbacterial prostatitis (CNP) has remained one of the most prevalent urological diseases, particularly in older men. Dihydroartemisinin (DHA) has been identified as a semi-synthetic derivative of artemisinin that exhibits broad protective effects. However, the role of DHA in inhibiting CNP inflammation and prostatic epithelial cell proliferation remains largely unknown.

View Article and Find Full Text PDF
Article Synopsis
  • - Nearly half of acute myeloid leukemia (AML) patients either do not respond to initial treatment or relapse quickly, but recent research indicates that the antibody flotetuzumab may be effective for these patients who have an immune-infiltrated tumor microenvironment.
  • - A study involving 88 adults with relapsed/refractory AML tested flotetuzumab, revealing manageable side effects and promising response rates, particularly among patients experiencing primary induction failure or early relapse.
  • - Of the patients who received the recommended dosage, roughly 26.7% achieved complete remission, while those who did had a median overall survival of 10.2 months, suggesting that flotetuzumab could be a viable treatment option for hard-to
View Article and Find Full Text PDF

Violaxanthin de-epoxidase (VDE) is a conditionally soluble enzyme located in the thylakoid lumen and catalyses the conversion of violaxanthin to antheraxanthin and zeaxanthin, which are located in the thylakoid membrane. These reactions occur when the plant or algae are exposed to saturating light and the zeaxanthin formed is involved in the process of non-photochemical quenching that protects the photosynthetic machinery during stress. Oversaturation by light results in a reduction of the pH inside the thylakoids, which in turn activates VDE and the de-epoxidation of violaxanthin.

View Article and Find Full Text PDF

Photosynthetic organisms need protection against excessive light. By using non-photochemical quenching, where the excess light is converted into heat, the organism can survive at higher light intensities. This process is partly initiated by the formation of zeaxanthin, which is achieved by the de-epoxidation of violaxanthin and antheraxanthin to zeaxanthin.

View Article and Find Full Text PDF

Violaxanthin de-epoxidase (VDE) catalyses the conversion of violaxanthin to zeaxanthin at the lumen side of the thylakoids during exposure to intense light. VDE consists of a cysteine-rich N-terminal domain, a lipocalin-like domain and a negatively charged C-terminal domain. That the cysteines are important for the activity of VDE is well known, but in what way is less understood.

View Article and Find Full Text PDF

Background: Direct comparisons of similar doses of a novel influenza virus antigen administered by the intradermal route and the intramuscular route have not been reported.

Methods: A total of 227 healthy adults aged 18-49 years were randomized to receive 2 doses 1 month apart of a subvirion inactivated influenza A virus subtype H5N1 (rgA/Vietnam/1203/2004) vaccine containing 38.7 μg of H5N1 hemagglutinin (HA), by the intramuscular route or by the intradermal route using the Mantoux technique.

View Article and Find Full Text PDF

Avian influenza A/H9N2 viruses can infect people and are viruses considered to be a potential pandemic threat. Prior studies with an inactivated G1 clade H9N2 vaccine reported that persons born before 1968 were more likely to have an immune response than younger subjects. We performed a randomized, double-blind trial to evaluate whether immune responses following immunization with an inactivated, unadjuvanted influenza G9 H9N2 vaccine prepared from A/chicken/Hong Kong/G9/97 virus were more frequent in persons born in 1964 or earlier (44-59 years) than in those born in 1970 or later (18-38 years).

View Article and Find Full Text PDF

Dosage-sparing strategies, adjuvants and alternative substrates for vaccine production are being explored for influenza vaccine development. We assessed the safety and immunogenicity of a Vero cell culture-grown inactivated whole virus influenza A/H5N1 vaccine with or without aluminum hydroxide adjuvant [Al(OH)(3)] in healthy young adults. Vaccines were well tolerated, but injection site discomfort was more frequent in groups receiving Al(OH)(3).

View Article and Find Full Text PDF

A total of 600 healthy adults > or =65 years were randomized to receive 2 vaccinations 1 month apart of a subvirion avian influenza A/H5N1 vaccine containing 3.75, 7.5, 15, or 45microg of hemagglutinin (HA) with or without aluminum hydroxide (AlOH).

View Article and Find Full Text PDF